Late transcatheter heart valve leaflet thrombosis

Late transcatheter heart valve leaflet thrombosis - Late THV thrombosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1090220334

Enrollment

133

Registered

2018-02-27

Start date

2018-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who had undergone transcatheter aortic valve implantation for aortic stenosis more than three years ago

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who had undergone transcatheter aortic valve implantation in Sakakibara Heart Institute from October 2013 to December 2015

Exclusion criteria

Exclusion criteria: death, patient refusal, poor general condition, allergy of contrast media, renal dysfunction (eGFR<45)

Design outcomes

Primary

Measure	Time frame
transcatheter heart valve leaflet thrombosis	—

Secondary

Measure	Time frame
1. bioprosthetic valve failure, 2. structural valve deterioration	—

Countries

Japan

Contacts

Public ContactRyosuke Higuchi

Sakakibara Heart institute

rhiguchi@shi.heart.or.jp+81-42-314-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026